Some medicines used for heart problems, like beta-blockers, ACE inhibitors, and calcium channel blockers, have been known to ...

For patients with psoriasis and Type 2 diabetes, the risk of developing chronic kidney disease (CKD) continued to rise ...

AD and psoriasis were once thought to be opposites in terms of immune response, with AD linked to a Th2-dominant pathway and ...

Skin diseases contribute significantly to morbidity worldwide, yet their burden in North Africa and the Middle East (NAME) remains poorly understood. This study aims to assess the burden of skin ...

Tumor necrosis factor-alpha (TNF-α) and interleukin (IL) inhibitors are biologic agents that selectively inhibit cytokines involved in the pathogenesis of psoriasis (Table). 11,13 Biologics have ...

By Dr. Chinta Sidharthan New research highlights how elevated levels of the iron-regulating hormone hepcidin contribute to ...

Scientists believe the hormone hepcidin, when produced in the skin, may be the root cause of psoriasis – a chronic and sometimes debilitating skin disease that affects 2-3% of the global ...

Pathogenesis of Psoriasis For most of its history, psoriasis has been thought of as a disease localized to the skin and primarily being driven by abnormalities in keratinocytes.

The management of psoriasis revolves around injectable biologics that target T helper 17 cells-derived proinflammatory cytokines responsible for the pathogenesis of the disease. IL-23 inhibitors ...

Both companies have found answers in each other. Oruka and ARCA are pursuing a reverse merger intended to create a $300 million-plus combined company focused on treating plaque psoriasis and other ...

Data demonstrate superiority vs. placebo in preventing generalized pustular psoriasis (GPP) flares up to 48 weeks 1 Prevention of unpredictable flares addresses a high unmet patient need 2,3 ...